This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 12/03/2014
PIL Fluarix

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/03/2014 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision
Updated on 03/09/2013 and displayed until 12/03/2014
Reasons for adding or updating:
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision
Updated on 14/05/2013 and displayed until 03/09/2013
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 03/09/2012 and displayed until 14/05/2013
Reasons for adding or updating:
  • Change of active ingredient
  • Change to date of revision
Updated on 16/03/2012 and displayed until 03/09/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 31/10/2011 and displayed until 16/03/2012
Reasons for adding or updating:
  • Unknown
Updated on 25/05/2011 and displayed until 31/10/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 10/08/2010 and displayed until 25/05/2011
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to Further Information section
  • Change to date of revision
  • Change of contra-indications
Updated on 21/09/2009 and displayed until 10/08/2010
Reasons for adding or updating:
  • Change of active ingredient
  • Change to date of revision
Updated on 11/02/2009 and displayed until 21/09/2009
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 06/02/2009 and displayed until 11/02/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/08/2008 and displayed until 06/02/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to date of revision
  • Change of active ingredient
Updated on 05/09/2007 and displayed until 26/08/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change of active ingredient
Updated on 26/09/2006 and displayed until 05/09/2007
Reasons for adding or updating:
  • Change of active ingredient
  • Change to date of revision
Updated on 29/09/2005 and displayed until 26/09/2006
Reasons for adding or updating:
  • Change of active ingredient
  • Change of inactive ingredient
  • Change to date of revision
Updated on 18/08/2004 and displayed until 29/09/2005
Reasons for adding or updating:
  • Change of active ingredient
  • Change to date of revision
Updated on 15/07/2003 and displayed until 18/08/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 20/08/2002 and displayed until 15/07/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 10/05/2002 and displayed until 20/08/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 01/11/2000 and displayed until 10/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics